Nasopharyngeal carcinoma (npc) Clinical Trials
Conditions / Nasopharyngeal carcinoma (npc)
Delta Trials tracks 28 clinical trials for Nasopharyngeal carcinoma (npc) in its publicly accessible dataset. Among the listed trials, 17 open for participant enrollment and 2 trials have reached completion. This research is carried out at 50 clinical sites around the world. An additional 9 trials have active registrations outside the recruiting and completed categories. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the research landscape.
Trial Status
28
Total Trials
17
Recruiting
2
Completed
9
Other Active
0
Terminated since 2020
50
Study Locations
Browse by location (50 total)
- Guangzhou, China 8 trialsAll trials in Guangzhou, China
- Nanning, China 5 trialsAll trials in Nanning, China
- Wuhan, China 4 trialsAll trials in Wuhan, China
- Hangzhou, China 3 trialsAll trials in Hangzhou, China
- Changsha, China 3 trialsAll trials in Changsha, China
- Nanchang, China 3 trialsAll trials in Nanchang, China
- Zhuhai, China 3 trialsAll trials in Zhuhai, China
- Guangdong, China 2 trialsAll trials in Guangdong, China
- Jinan, China 2 trialsAll trials in Jinan, China
- Jinan, China 2 trialsAll trials in Jinan, China
- Chengdu, China 2 trialsAll trials in Chengdu, China
- Shanghai, China 2 trialsAll trials in Shanghai, China
- Dongguan, China 1 trialAll trials in Dongguan, China
- Blacktown, Australia 1 trialAll trials in Blacktown, Australia
- Shenzhen, China 1 trialAll trials in Shenzhen, China
- Shantou, China 1 trialAll trials in Shantou, China
- Kuala Lumpur, Malaysia 1 trialAll trials in Kuala Lumpur, Malaysia
- Clayton, Australia 1 trialAll trials in Clayton, Australia
- Changhua, Taiwan 1 trialAll trials in Changhua, Taiwan
- Brisbane, Australia 1 trialAll trials in Brisbane, Australia